235 related articles for article (PubMed ID: 22727601)
1. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies.
Du Four S; Wilgenhof S; Duerinck J; Michotte A; Van Binst A; De Ridder M; Neyns B
Eur J Cancer; 2012 Nov; 48(16):3045-51. PubMed ID: 22727601
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
[TBL] [Abstract][Full Text] [Related]
3. The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.
Kaidar-Person O; Zagar TM; Deal A; Moschos SJ; Ewend MG; Sasaki-Adams D; Lee CB; Collichio FA; Fried D; Marks LB; Chera BS
Anticancer Drugs; 2017 Jul; 28(6):669-675. PubMed ID: 28368903
[TBL] [Abstract][Full Text] [Related]
4. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery.
Mathew M; Tam M; Ott PA; Pavlick AC; Rush SC; Donahue BR; Golfinos JG; Parker EC; Huang PP; Narayana A
Melanoma Res; 2013 Jun; 23(3):191-5. PubMed ID: 23462208
[TBL] [Abstract][Full Text] [Related]
5. Melanoma in the brain: biology and therapeutic options.
Gibney GT; Forsyth PA; Sondak VK
Melanoma Res; 2012 Jun; 22(3):177-83. PubMed ID: 22495668
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.
Schmidberger H; Rapp M; Ebersberger A; Hey-Koch S; Loquai C; Grabbe S; Mayer A
Strahlenther Onkol; 2018 Dec; 194(12):1144-1151. PubMed ID: 30298365
[TBL] [Abstract][Full Text] [Related]
7. Multimodality management of brain metastases in metastatic melanoma patients.
Samlowski WE; Jensen RL; Shrieve DC
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1699-705. PubMed ID: 18062744
[TBL] [Abstract][Full Text] [Related]
8. Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.
Milsch L; Gesierich A; Kreft S; Livingstone E; Zimmer L; Goebeler M; Schadendorf D; Schilling B
Eur J Cancer; 2018 Aug; 99():58-65. PubMed ID: 29906735
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic strategies and systemic treatment of brain melanoma metastases].
Durando X; Mansard S; Daste A; Gimbergues P; Brocard L; Magné N; Thivat E
Bull Cancer; 2013 Jan; 100(1):23-8. PubMed ID: 22889847
[TBL] [Abstract][Full Text] [Related]
10. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
[TBL] [Abstract][Full Text] [Related]
11. [Melanoma brain metastases : Treatment options].
Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
[TBL] [Abstract][Full Text] [Related]
12. The role of systemic therapies in the management of melanoma brain metastases.
Lyle M; Long GV
Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
[TBL] [Abstract][Full Text] [Related]
13. The abscopal effect associated with a systemic anti-melanoma immune response.
Stamell EF; Wolchok JD; Gnjatic S; Lee NY; Brownell I
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):293-5. PubMed ID: 22560555
[TBL] [Abstract][Full Text] [Related]
14. Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
Konstantinou MP; Dutriaux C; Gaudy-Marqueste C; Mortier L; Bedane C; Girard C; Thellier S; Jouary T; Grob JJ; Richard MA; Templier C; Sakji L; Guillot B; Paul C; Meyer N
Acta Derm Venereol; 2014 Jan; 94(1):45-9. PubMed ID: 23824275
[TBL] [Abstract][Full Text] [Related]
15. Ipilimumab in advanced melanoma: reports of long-lasting responses.
Farolfi A; Ridolfi L; Guidoboni M; Nicoletti SV; Piciucchi S; Valmorri L; Costantini M; Scarpi E; Amadori D; Ridolfi R
Melanoma Res; 2012 Jun; 22(3):263-70. PubMed ID: 22516968
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
17. Ipilimumab and radiation therapy for melanoma brain metastases.
Silk AW; Bassetti MF; West BT; Tsien CI; Lao CD
Cancer Med; 2013 Dec; 2(6):899-906. PubMed ID: 24403263
[TBL] [Abstract][Full Text] [Related]
18. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome.
Panagiotou IE; Brountzos EN; Kelekis DA; Papathanasiou MA; Bafaloukos DI
Neoplasma; 2005; 52(2):150-8. PubMed ID: 15800714
[TBL] [Abstract][Full Text] [Related]
19. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
Margolin K; Ernstoff MS; Hamid O; Lawrence D; McDermott D; Puzanov I; Wolchok JD; Clark JI; Sznol M; Logan TF; Richards J; Michener T; Balogh A; Heller KN; Hodi FS
Lancet Oncol; 2012 May; 13(5):459-65. PubMed ID: 22456429
[TBL] [Abstract][Full Text] [Related]
20. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]